Eldorado Hotel & Spa Floorplan
This meeting took place in 2022
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
Exosomes, Microvesicles and Other Extracellular Vesicles - RESCHEDULED (RB3)
Organizer(s) Clotilde Thery, Andrew Hill and Susmita Sahoo
October 30—November 2, 2022
Eldorado Hotel & Spa • Santa Fe, NM USA
Abstract Deadline: Jul 28, 2022
Scholarship Deadline: Nov 9, 2021
Discounted Registration Deadline: Aug 30, 2022
Sponsored by Cell Research, Chinese Society for Cell Biology, (Cell Research), Ionis Pharmaceuticals, Inc., Moderna, Takeda Pharmaceutical Company Limited and Ultragenyx Pharmaceutical Inc.
Summary of Meeting:
Extracellular vesicles (EVs), including exosomes, microvesicles and others are membranous nanovesicles, contain bioactive molecules such as lipids, proteins, RNA and metabolites derived from the cell of their origin. EVs carry these important cargo molecules throughout the body, signaling to distant tissues and orchestrating systemic responses. The profile of cargo they carry provides a cell-specific signature, which can reveal important insights about the cell of origin, and pathophysiological mechanisms. As such, there is growing excitement about their potential use as disease biomarkers, and/or therapeutic entities. The goal of this meeting is to disseminate the latest discoveries regarding both basic biology and clinical utility of EVs. In particular, the program will explore the role of EVs in human disease pathogenesis, novel therapeutic approaches with EVs, and biomarker developments. In addition to scientific insights, the meeting will cover new methodologies, tools and technologies for studying EVs, to enable further advancements in characterization of EV processes and facilitate translational impact into diagnostic and therapeutic applications. By integrating research in basic science with the clinical perspectives, this meeting will foster cross-disciplinary discussions and collaborations to drive the field forward towards medical impacts. In addition, the program format features panel discussions and workshops to spur insightful discussions and encourage interactions between young investigators and distinguished international experts for training, mentorship and networking opportunities.
View Scholarships/Awards
Extracellular vesicles (EVs), including exosomes, microvesicles and others are membranous nanovesicles, contain bioactive molecules such as lipids, proteins, RNA and metabolites derived from the cell of their origin. EVs carry these important cargo molecules throughout the body, signaling to distant tissues and orchestrating systemic responses. The profile of cargo they carry provides a cell-specific signature, which can reveal important insights about the cell of origin, and pathophysiological mechanisms. As such, there is growing excitement about their potential use as disease biomarkers, and/or therapeutic entities. The goal of this meeting is to disseminate the latest discoveries regarding both basic biology and clinical utility of EVs. In particular, the program will explore the role of EVs in human disease pathogenesis, novel therapeutic approaches with EVs, and biomarker developments. In addition to scientific insights, the meeting will cover new methodologies, tools and technologies for studying EVs, to enable further advancements in characterization of EV processes and facilitate translational impact into diagnostic and therapeutic applications. By integrating research in basic science with the clinical perspectives, this meeting will foster cross-disciplinary discussions and collaborations to drive the field forward towards medical impacts. In addition, the program format features panel discussions and workshops to spur insightful discussions and encourage interactions between young investigators and distinguished international experts for training, mentorship and networking opportunities.
View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference
The meeting will begin on Sunday, October 30 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Wednesday, November 2 with a closing plenary session from 17:00 to 19:00, followed by a social hour. We recommend return travel on Thursday, November 3 in order to fully experience the meeting.
SUNDAY, OCTOBER 30
MONDAY, OCTOBER 31
TUESDAY, NOVEMBER 1
WEDNESDAY, NOVEMBER 2
THURSDAY, NOVEMBER 3
Conference Program Print | View meeting in 12 hr (am/pm) time
The meeting will begin on Sunday, October 30 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Wednesday, November 2 with a closing plenary session from 17:00 to 19:00, followed by a social hour. We recommend return travel on Thursday, November 3 in order to fully experience the meeting.
SUNDAY, OCTOBER 30
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.
08:00—11:00
EV Isolation, Characterization and Normalization (8:00-11:00 AM)
*
Andrew Hill,
Victoria University, Australia
Kenneth W. Witwer,
Johns Hopkins Medical Institutions, USA
Remote Presentation: Guidelines (MISEV2018), Rigor and Standardization Initiatives for EV Studies
Remote Presentation: Guidelines (MISEV2018), Rigor and Standardization Initiatives for EV Studies
Robert J. Coffey, Jr.,
Vanderbilt University Medical Center, USA
Update on Isolation and Characterization of Extracellular Vesicles and Nanoparticles
Update on Isolation and Characterization of Extracellular Vesicles and Nanoparticles
Coffee Break
Aleksandar Milosavljevic,
Baylor College of Medicine, USA
A Map of Extracellular RNA-Binding Proteins (exRBPs) and their exRNA Cargo in Human Biofluids
A Map of Extracellular RNA-Binding Proteins (exRBPs) and their exRNA Cargo in Human Biofluids
Cláudio Pinheiro,
Gent University, Belgium
Short Talk: Evaluation of Disparate Methods to Separate Extracellular Vesicles from Multiple Biofluids in the Extracellular Vesicle Quality Control (EVQC) Study
Short Talk: Evaluation of Disparate Methods to Separate Extracellular Vesicles from Multiple Biofluids in the Extracellular Vesicle Quality Control (EVQC) Study
Ariana K. von Lersner,
Vanderbilt University, USA
Short Talk: "EV Fingerprinting": Resolving the Heterogeneity of Extracellular Vesicle Populations using Dimensional Reduction of Multi-Parametric Flow Cytometry Data
Short Talk: "EV Fingerprinting": Resolving the Heterogeneity of Extracellular Vesicle Populations using Dimensional Reduction of Multi-Parametric Flow Cytometry Data
Lizandra Jimenez,
Vanderbilt University, USA
Short Talk: Evaluation of Culture Conditions on the Presence of Ago2 and miRNAs in Small Extracellular Vesicles
Short Talk: Evaluation of Culture Conditions on the Presence of Ago2 and miRNAs in Small Extracellular Vesicles
Ferdinando Pucci,
Oregon Health & Science University, USA
Short Talk: “EV Painting” Uncovers Hidden Surface Interactions Between Tumor EVs and Immune Cells in vivo
Short Talk: “EV Painting” Uncovers Hidden Surface Interactions Between Tumor EVs and Immune Cells in vivo
14:30—16:30
Hands On Workshop: Tools for Analysis of RNA Sequencing Data in Extracellular RNA and EVs (2:30-4:30 PM)
*
Roger P. Alexander,
Extracellular RNA Communication Consortium, USA
Using the exceRpt Small-exRNA-seq Processing Pipeline: A Case Study on the Impact of Exercise
Using the exceRpt Small-exRNA-seq Processing Pipeline: A Case Study on the Impact of Exercise
Antonin Morillon,
Institut Curie, France
Characterization of the Long Noncoding Transcriptome from Urinary Extracellular Vesicles of Prostate Cancer Patients
Characterization of the Long Noncoding Transcriptome from Urinary Extracellular Vesicles of Prostate Cancer Patients
Robert Fullem,
Baylor College of Medicine, USA
exRNA Data Slicer: Find your Regions of Interest in the exRNA Atlas
exRNA Data Slicer: Find your Regions of Interest in the exRNA Atlas
Navneet Dogra,
Icahn School of Medicine at Mount Sinai, USA
Characterizing the Neurosecretome: Extracellular Particles of the Brain and their Lineage in Blood
Characterizing the Neurosecretome: Extracellular Particles of the Brain and their Lineage in Blood
17:00—19:15
Biogenesis and Transfer of EVs (5:00-7:15 PM)
*
Rania Ghossoub,
INSERM U1068, France
Pascale Zimmermann,
Centre de Recherche en Cancerologie de Marseille and KU Leuven, France
Syntenin-Dependent Exosome Formation and Induced Molecular Signaling in Cell-to-Cell Communication
Syntenin-Dependent Exosome Formation and Induced Molecular Signaling in Cell-to-Cell Communication
Maureen M. Barr,
Rutgers University, USA
Cilia-Derived Vesicle Biogenesis and Signaling in Animal Communication
Cilia-Derived Vesicle Biogenesis and Signaling in Animal Communication
Niek Dekker,
AstraZeneca, Sweden
Engineered Extracellular Vesicles for Drug Delivery for Regenerative Therapy
Engineered Extracellular Vesicles for Drug Delivery for Regenerative Therapy
Bahnisikha Barman,
Vanderbilt University, USA
Short Talk: VAP-A-CERT Linkages at ER-Membrane Contact Sites Regulate Biogenesis of RNA Containing Extracellular Vesicles
Short Talk: VAP-A-CERT Linkages at ER-Membrane Contact Sites Regulate Biogenesis of RNA Containing Extracellular Vesicles
Daniel Humphrys,
University of Washington, USA
Short Talk: Functionalizing the Membrane of Enveloped Protein Nanocages
Short Talk: Functionalizing the Membrane of Enveloped Protein Nanocages
Justin Williams,
UC Berkeley, USA
Short Talk: Annexin A6 Mediates Calcium-dependent Exosome Secretion
Short Talk: Annexin A6 Mediates Calcium-dependent Exosome Secretion
19:15—20:15
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
08:00—10:15
EVs and Cancer (8:00-10:15 AM)
*
Robert J. Coffey, Jr.,
Vanderbilt University Medical Center, USA
Michele De Palma,
École Polytechnique Fédérale de Lausanne, Switzerland
Remote Presentation: Harnessing Tumor-Derived Extracellular Vesicles for Cancer Therapy
Remote Presentation: Harnessing Tumor-Derived Extracellular Vesicles for Cancer Therapy
Clotilde Théry,
Institut Curie, France
Exosomes and Other EVs in Tumor-Immune System Cross-Talk
Exosomes and Other EVs in Tumor-Immune System Cross-Talk
Coffee Break
Wei Guo,
University of Pennsylvania, USA
Exosomes in Immune Suppression and Tumor Progression
Exosomes in Immune Suppression and Tumor Progression
Nuno Bastos,
i3S - Institute for Research and Innovation in Health, Porto, Portugal
Short Talk: Loss of Rab27a in Pancreatic Cancer Steers an Inflammatory Microenvironment that Promotes Disease Progression
Short Talk: Loss of Rab27a in Pancreatic Cancer Steers an Inflammatory Microenvironment that Promotes Disease Progression
10:15—11:45
EVs in Aging-Nervous System (10:15-11:45 AM)
*
Christian Neri,
IBPS, Sorbonne University, France
Andrew Hill,
Victoria University, Australia
EVs in Neurodegenerative Diseases
EVs in Neurodegenerative Diseases
Efrat Levy,
NYU Langone Health, USA
Mitovesicles are Central to Neuronal Integrity in Aging and in Neurodegenerative Diseases
Mitovesicles are Central to Neuronal Integrity in Aging and in Neurodegenerative Diseases
Michael Hantak,
University of Utah, USA
Short Talk: Arc EVs are Virus-like Intercellular Communicators
Short Talk: Arc EVs are Virus-like Intercellular Communicators
Natayme Rocha Tartaglia,
Sorbonne University, France
Short Talk: Extracellular Vesicle Remodeling in Response to Mutant Huntingtin
Short Talk: Extracellular Vesicle Remodeling in Response to Mutant Huntingtin
15:30—16:30
Career Roundtable (3:30-4:30 PM)
Elena Aikawa,
Harvard Medical School, Brigham and Women’s Hospital, USA
Niek Dekker,
AstraZeneca, Sweden
Navneet Dogra,
Icahn School of Medicine at Mount Sinai, USA
17:00—19:00
EVs and Cardio-Metabolic Physio/pathology (5:00-7:00 PM)
Clair Crewe,
Washington University School of Medicine in St. Louis, USA
Adipocyte Energetic Stress Induces Mitochondrial-Derived Extracellular Vesicle Production to Regulate Systemic Metabolism
Adipocyte Energetic Stress Induces Mitochondrial-Derived Extracellular Vesicle Production to Regulate Systemic Metabolism
Elena Aikawa,
Harvard Medical School, Brigham and Women’s Hospital, USA
The Role of Extracellular Vesicles in Cardiovascular Calcification
The Role of Extracellular Vesicles in Cardiovascular Calcification
*
Susmita Sahoo,
Icahn School of Medicine at Mount Sinai, USA
EVs in Myocardial Gene Delivery
EVs in Myocardial Gene Delivery
Alan M. Adamczyk,
University Of Buenos Aires, Argentina
Short Talk: Plasma Extracellular Vesicles Dampen Macrophage-driven Inflammation
Short Talk: Plasma Extracellular Vesicles Dampen Macrophage-driven Inflammation
Tamires Marques Zanotto,
State University of Campinas, Brazil
Short Talk: Designing a New Therapeutic Approach using Exosomal miRNAs to Target Metabolic Disease: PCSK9 Inhibition Effects in Reducing Atherosclerosis Risk
Short Talk: Designing a New Therapeutic Approach using Exosomal miRNAs to Target Metabolic Disease: PCSK9 Inhibition Effects in Reducing Atherosclerosis Risk
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
08:00—11:00
Non Mammalian EVs and Viruses (8:00-11:00 AM)
*
Clotilde Théry,
Institut Curie, France
Matias Ostrowski,
University of Buenos Aires, Argentina
Remote Presentation: HIV Pathogenesis and Extracellular Vesicles-Mediated Inflammation
Remote Presentation: HIV Pathogenesis and Extracellular Vesicles-Mediated Inflammation
Esther Nolte-'t Hoen,
Utrecht University, Netherlands
Viral and Host Mechanisms Driving the Release of EV-Enclosed Picornaviruses
Viral and Host Mechanisms Driving the Release of EV-Enclosed Picornaviruses
Coffee Break
Tanina Arab,
Johns Hopkins University, USA
Short Talk: EV Packaging of U6 Small Nuclear RNA in SIV Infection
Short Talk: EV Packaging of U6 Small Nuclear RNA in SIV Infection
Daniel C. Rabe,
Massachusetts General Hospital, USA
Short Talk: Microfluidic Detection of SARS-CoV-2 and Virus-Related Extracellular Vesicles to Predict Outcome in COVID-19 Patients
Short Talk: Microfluidic Detection of SARS-CoV-2 and Virus-Related Extracellular Vesicles to Predict Outcome in COVID-19 Patients
Aadil Sheikh,
Baylor University, USA
Short Talk: Bacteria-Derived Outer Membrane Vesicles Contain Unique Small RNA Species and Interact with Host Cells
Short Talk: Bacteria-Derived Outer Membrane Vesicles Contain Unique Small RNA Species and Interact with Host Cells
Danilo Rodrigues da Silva,
University of Florida, USA
Short Talk: Mammalian Cell Internalization of Lactobacillus Johnsonii N6.2 Derived Nanovesicles Induce Upregulation of Cellular Immune Response
Short Talk: Mammalian Cell Internalization of Lactobacillus Johnsonii N6.2 Derived Nanovesicles Induce Upregulation of Cellular Immune Response
17:00—18:45
Novel Technological Developments (5:00-6:45 PM)
*
Alissa M. Weaver,
Vanderbilt University School of Medicine, USA
Jennifer C. Jones,
NCI, National Institutes of Health, USA
Remote Presentation: New Approaches to Individual EV Assays and EV Repertoire Studies
Remote Presentation: New Approaches to Individual EV Assays and EV Repertoire Studies
Chioma Okeoma,
Stony Brook University, USA
Novel Technology for Nano-particle Isolation
Novel Technology for Nano-particle Isolation
Thomas Gaborrski,
Rochester Institute of Technology, USA
Short Talk: Development of Nanopocket Membranes for the Purification and Fractionation of Extracellular Vesicle Subpopulations
Short Talk: Development of Nanopocket Membranes for the Purification and Fractionation of Extracellular Vesicle Subpopulations
Qin Zhang,
Vanderbilt University Medical Center, USA
Short Talk: Supermeres are Functional Extracellular Nanoparticles Replete with Disease Biomarkers and Therapeutic Targets
Short Talk: Supermeres are Functional Extracellular Nanoparticles Replete with Disease Biomarkers and Therapeutic Targets
Olesia Gololobova,
Johns Hopkins University, USA
Short Talk: Asymmetric Flow Field-Flow Fractionation for Separation and Characterization of exRNA Carriers: Blood Plasma Lipoproteins and Extracellular Vesicles
Short Talk: Asymmetric Flow Field-Flow Fractionation for Separation and Characterization of exRNA Carriers: Blood Plasma Lipoproteins and Extracellular Vesicles
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
*Session Chair †Invited, not yet responded.
Keystone Symposia thanks our Sponsors(s) for generously supporting this meeting:
|
|
|
|
|
|
We gratefully acknowledge additional support from these exhibitors at this conference:
|
|
Please stop by to meet these exhibitors during the conference.
We gratefully acknowledge the generous grant for this conference provided by:
We gratefully acknowledge additional support for this conference from:
|
|
|
|
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:
Click here to view more of these organizations
|
If your organization is interested in joining these entities in support of Keystone
Symposia, please contact: John Monson,
Director of Corporate Relations, Email: johnm@keystonesymposia.org, Phone:+1 970-262-2690 Click here for more information on Industry Support and Recognition Opportunities. If you are interested in becoming an advertising/marketing in-kind partner, please contact: Nick Dua, Senior Director, Communications, Email: nickd@keystonesymposia.org, Phone:+1 970-262-1179 |
